sym-trinitrobenzene has been researched along with HIV Coinfection in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Avrameas, S; Guetard, D; Matsiota-Bernard, P; Montagnier, L; Rame, V | 1 |
Halsey, NA; Hampton, R; Hildreth, JE | 1 |
2 other study(ies) available for sym-trinitrobenzene and HIV Coinfection
Article | Year |
---|---|
Inhibition of in vitro HIV infection by trinitrophenyl-protein conjugates.
Topics: Animals; Antibodies, Monoclonal; Antiviral Agents; Cattle; CD4-Positive T-Lymphocytes; Cells, Cultured; HIV Infections; Humans; Immune Sera; Immunity, Innate; Leukocytes, Mononuclear; Serum Albumin; Trinitrobenzenes | 1995 |
Antibody-dependent cell-mediated cytotoxicity can protect PBMC from infection by cell-associated HIV-1.
Topics: Antibody-Dependent Cell Cytotoxicity; DNA, Viral; Haptens; HIV Antibodies; HIV Infections; HIV-1; Humans; Immunoglobulin G; In Vitro Techniques; Killer Cells, Natural; Leukocytes, Mononuclear; Neutralization Tests; T-Lymphocytes; Trinitrobenzenes | 1999 |